BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$1.32
-0.16 (-10.81%)
▼
5d:
-20.0%
30d:
-56.0%
90d:
-57.96%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jun 26, 2026
0d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BDRX is down 20.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BDRX is down 20.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $1.32, which is considered oversold relative to its 30-day fair value range of $1.67 to $2.76.
Technical Outlook: Technically, BDRX is showing sideways momentum. Immediate support is located at $1.02, while resistance sits at $2.17. Short-term momentum is weak, with the stock down 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.15 (+669.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is showing sideways momentum. Immediate support is located at $1.02, while resistance sits at $2.17. Short-term momentum is weak, with the stock down 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.15 (+669.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.67 -
$2.76
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.8%)
- BULLISH: Trading 669.0% below Wall St target ($10.15)
- WARNING: Recommendation downgraded due to -20.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.67 -
$2.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.02
Resistance Level
$2.17
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Wall Street Target
$10.15
(+669.0%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: August 03, 2026 2:57 AM ET
Data refreshes hourly during market hours. Next update: 3:57 AM
Data refreshes hourly during market hours. Next update: 3:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
